HD-OPM Archive
Topics › Heart attack, stroke & procedures

Tongxinluo, a traditional Chinese medicine, cut post-heart attack events in a JAMA trial

Louis Nervegna · May 31, 2024 · ♥ 8 reactions · 9 comments · original Facebook post
Heart attack, stroke & procedures
AI summary & key facts

Louis shares a Newsweek report on a large JAMA clinical trial of the traditional Chinese medicine tongxinluo in people after a first heart attack. The report says it reduced heart attacks, deaths and other major cardiovascular complications for at least a year. No effect sizes are given in the post.

“A traditional Chinese medicine has been shown to be effective at reducing complications following a heart attack after a large-scale, clinical trial.”

“The latest study, which has been published in JAMA (formerly The Journal of the American Medical Association), represents one of the first times that a traditional Chinese medicine has been tested in a large-scale, Western-style clinical trial.

The authors of the study, who include researchers from several Chinese universities and hospitals, in collaboration with experts from the University of Texas Southwestern Medical Center (UTSW)—found that tongxinluo reduced the risk of heart attacks (known as myocardial infarctions), deaths and other major cardiovascular complications for at least a year after a first heart attack.”

——

NewsweekTraditional Chinese medicine proves effective in modern clinical trialThe medicine is made from from various plants and animals, including such ingredients as scorpion and leech extracts.newsweek.com

#tcmHD #tongxinluoHD #heartattackHD

Research cited

← newer: U-shaped ApoB-mortality curve turns linear after adjusting folder: 37% of 237 ancient mummies had atherosclerosis on CT scans →